GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Equity-to-Asset

Bio-Gate AG (XTER:BIG1) Equity-to-Asset : 0.64 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bio-Gate AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €3.37 Mil. Bio-Gate AG's Total Assets for the quarter that ended in Dec. 2023 was €5.26 Mil. Therefore, Bio-Gate AG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.64.

The historical rank and industry rank for Bio-Gate AG's Equity-to-Asset or its related term are showing as below:

XTER:BIG1' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.23   Med: 0.55   Max: 0.7
Current: 0.64

During the past 13 years, the highest Equity to Asset Ratio of Bio-Gate AG was 0.70. The lowest was 0.23. And the median was 0.55.

XTER:BIG1's Equity-to-Asset is ranked better than
50.35% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs XTER:BIG1: 0.64

Bio-Gate AG Equity-to-Asset Historical Data

The historical data trend for Bio-Gate AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Equity-to-Asset Chart

Bio-Gate AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.47 0.70 0.67 0.64

Bio-Gate AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.55 0.67 0.67 0.64

Competitive Comparison of Bio-Gate AG's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Bio-Gate AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Gate AG's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Gate AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bio-Gate AG's Equity-to-Asset falls into.



Bio-Gate AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bio-Gate AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=3.37/5.259
=0.64

Bio-Gate AG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=3.37/5.259
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Gate AG  (XTER:BIG1) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Bio-Gate AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bio-Gate AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Gate AG (XTER:BIG1) Business Description

Traded in Other Exchanges
Address
Neumeyerstraße 28-34, Nürnberg, DEU
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Executives
Karl Richter Supervisory Board

Bio-Gate AG (XTER:BIG1) Headlines

No Headlines